Novel Research Grants Push Discoveries News and Stories 10 New Grants, 10 New Insights The path to safe and effective treatments and ultimately a cure lies in bold,...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints News and Stories Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...
